Huateng Pharma Develpoed Kinds Of Intermediates For Carfilzomib

Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.
By: Huateng Pharm
CHANGSHA, China - May 20, 2020 - PRLog -- Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.

Carfilzomib is derived from epoxomicin, a natural product that was shown by the laboratory of Craig Crews at Yale University to inhibit the proteasome. The Crews laboratory subsequently invented a more specific derivative of epoxomicin named YU101, which was licensed to Proteolix, Inc. Scientists at Proteolix invented a new, distinct compound that had potential use as a drug in humans, known as carfilzomib. Proteolix advanced carfilzomib to multiple Phase 1 and 2 clinical trials, including a pivotal phase 2 clinical trial designed to seek accelerated approval. Clinical trials for carfilzomib continue under Onyx Pharmaceuticals, which acquired Proteolix in 2009.

Carfilzomib covalently irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S proteasome, an enzyme that degrades unwanted cellular proteins. Carfilzomib displays minimal interactions with non-proteasomal targets, thereby improving safety profiles over bortezomib. Inhibition of proteasome-mediated proteolysis results in a build-up of polyubiquitinated proteins, which may cause cell cycle arrest, apoptosis, and inhibition of tumor growth.

Huateng Pharma develpoed several kinds of intermediates for Carfilzomib with high quality & fast shipping. We are able to provide the services of Anti-Cancer intermediates' process development and scale-up production with capacities varying from gram to kilograms and multi tons.

Today I want to introdude two kinds of intermediates for Carfilzomib from Huateng Pharma.

Product name: 1-​Pentanone,2-​amino-​4-​methyl-​1-​[(2R)​-​2-​methyl-​2-​oxiranyl]​-​,(2S)​-​,2,​2,​2-​trifluoroacetate(1:1)

CAS NO.: 247068-85-5

Catalog ID: 98534

Purity: 98%

Molecular formula: C9H17NO2.C2Hf3O2

Molecular weight: 285.26

Product name: (S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate

CAS NO.: 868539-96-2

Catalog ID: 99702

Purity: 98%

Molecular formula: C31H43N3O6

Molecular weight: 553.696

Company: Hunan Huateng Pharmaceutical Co. Ltd.

Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, P.R. China

Zip code: 410205

Telephone: +86 731 89916275

Fax: +86 0731-82251112-818



About us: Human Huateng Pharmaceutical Co., Ltd. is a leading and professional manufacturer which can provide PEG derivatives, biochemical reagents, pharmaceutical intermediates, APIs, Vitamin D Derivatives and targeted anti-tumor drugs.

Hunan Huateng Pharmaceutical Co. Ltd.
Source:Huateng Pharm
Posted By:*** Email Verified
Location:Changsha - Hunan - China
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Huateng Pharma PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share